Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3940427
Max Phase: Preclinical
Molecular Formula: C13H20O
Molecular Weight: 192.30
Molecule Type: Small molecule
Associated Items:
ID: ALA3940427
Max Phase: Preclinical
Molecular Formula: C13H20O
Molecular Weight: 192.30
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCCC1C=CC(=O)/C1=C/C(C)C
Standard InChI: InChI=1S/C13H20O/c1-4-5-6-11-7-8-13(14)12(11)9-10(2)3/h7-11H,4-6H2,1-3H3/b12-9+
Standard InChI Key: OVEVORNQNNKISM-FMIVXFBMSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 192.30 | Molecular Weight (Monoisotopic): 192.1514 | AlogP: 3.51 | #Rotatable Bonds: 4 |
Polar Surface Area: 17.07 | Molecular Species: NEUTRAL | HBA: 1 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 1 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 4.23 | CX LogD: 4.23 |
Aromatic Rings: 0 | Heavy Atoms: 14 | QED Weighted: 0.62 | Np Likeness Score: 1.73 |
1. (2004) Cyclopentanone and cyclopentanone derivatives as potent activators of HSF-1, |
Source(1):